- Home
- AXSM vs BEPC Comparison
AXSM vs BEPC Comparison
Compare AXSM & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- BEPC
- Stock Information
- Founded
- AXSM 2012
- BEPC 2019
- Country
- AXSM United States
- BEPC United States
- Employees
- AXSM N/A
- BEPC N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- BEPC Electric Utilities: Central
- Sector
- AXSM Health Care
- BEPC Utilities
- Exchange
- AXSM Nasdaq
- BEPC Nasdaq
- Market Cap
- AXSM 5.1B
- BEPC 6.1B
- IPO Year
- AXSM 2015
- BEPC N/A
- Fundamental
- Price
- AXSM $116.62
- BEPC $33.94
- Analyst Decision
- AXSM Strong Buy
- BEPC Buy
- Analyst Count
- AXSM 17
- BEPC 4
- Target Price
- AXSM $175.76
- BEPC $35.00
- AVG Volume (30 Days)
- AXSM 576.1K
- BEPC 701.4K
- Earning Date
- AXSM 11-11-2025
- BEPC 11-07-2025
- Dividend Yield
- AXSM N/A
- BEPC 4.39%
- EPS Growth
- AXSM N/A
- BEPC N/A
- EPS
- AXSM N/A
- BEPC N/A
- Revenue
- AXSM $495,033,000.00
- BEPC $3,882,000,000.00
- Revenue This Year
- AXSM $63.78
- BEPC $49.52
- Revenue Next Year
- AXSM $55.74
- BEPC $9.58
- P/E Ratio
- AXSM N/A
- BEPC N/A
- Revenue Growth
- AXSM 69.83
- BEPC N/A
- 52 Week Low
- AXSM $75.56
- BEPC $23.73
- 52 Week High
- AXSM $139.13
- BEPC $37.00
- Technical
- Relative Strength Index (RSI)
- AXSM 48.36
- BEPC 50.58
- Support Level
- AXSM $112.90
- BEPC $33.54
- Resistance Level
- AXSM $130.00
- BEPC $34.85
- Average True Range (ATR)
- AXSM 3.70
- BEPC 0.63
- MACD
- AXSM -1.47
- BEPC 0.09
- Stochastic Oscillator
- AXSM 21.75
- BEPC 56.46
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About BEPC Brookfield Renewable Corporation
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.